中国麻风皮肤病杂志 ›› 2026, Vol. 42 ›› Issue (2): 83-87.doi: 10.12144/zgmfskin202602083

• 论著 • 上一篇    下一篇

白癜风与代谢综合征及其组分的相关性分析

何一凡,周楠,孔庆涛,桑红   

  1. 南京大学医学院附属金陵医院(东部战区总医院)皮肤科,江苏南京,210002
  • 出版日期:2026-02-15 发布日期:2026-01-28

Association between vitiligo and metabolic syndrome and its components

HE Yifan, ZHOU Nan, KONG Qingtao, SANG Hong   

  1. Department of Dermatology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210002, China
  • Online:2026-02-15 Published:2026-01-28

摘要: 目的:比较白癜风患者与非白癜风人群代谢综合征(MS)及其组分的差异,明确代谢综合征与白癜风的相关性。方法:2022年2~11月就诊于我院皮肤科门诊的18周岁以上的非节段性白癜风患者设为病例组,同期至我院体检中心体检的非白癜风人群设为对照组。分析比较两组间体质指数(BMI)、血压、空腹血糖、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇、甘油三酯、总胆固醇水平及MS患病率。分析病例组白癜风病程、严重程度评分和疾病活动性评分及白癜风与代谢紊乱的相关性。结果:本研究纳入非节段性白癜风患者及对照各72例。白癜风组的BMI、DBP水平及高血压和血脂紊乱患病率均高于对照组(均P<0.05);BMI水平、高血压患病率和血脂紊乱患病率与白癜风病程、疾病严重程度评分、活动度评分均无显著相关性(均P>0.05)。 结论:白癜风患者具有更严重的MS相关代谢紊乱,但代谢紊乱与白癜风病程、疾病严重程度和活动度无明显相关性。

关键词: 白癜风, 代谢综合征, 体质指数, 高血压, 血脂紊乱

Abstract: Objective: To compare the differences in metabolic syndrome (MS) and its components between patients with vitiligo and non-vitiligo individuals, and to clarify the correlation between metabolic syndrome and vitiligo. Methods: Non-segmental vitiligo patients aged ≥18 years who attended the department of dermatology of our school from February to November 2022 were assigned to the case group, while non-vitiligo individuals who underwent physical examination at the hospital's health check-up center during the same period were selected as the control group. The levels of body mass index (BMI), blood pressure, fasting blood glucose, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, total cholesterol, and the prevalence of MS were compared between the two groups. For the case group, the course of vitiligo, severity score, and disease activity score were investigated to analyze the correlation between vitiligo and metabolic disorders. Results: A total of 72 non-segmental vitiligo patients and 72 controls were included in the study. The BMI, diastolic blood pressure (DBP) levels, and the prevalence of hypertension and dyslipidemia in the vitiligo group were significantly higher than those in the control group (Ps<0.05). However, no significant correlations were found between BMI, the prevalence of hypertension or dyslipidemia and the course, severity score, or activity score of vitiligo (Ps>0.05). Conclusion: Patients with vitiligo have more severe MS-related metabolic disorders, which are not significantly associated with the course, severity, or activity of vitiligo.

Key words: vitiligo, metabolic syndrome, BMI, hypertension, dyslipidemia